XHS - SPDR S&P Health Care Services ETF

NYSEArca - NYSEArca Delayed Price. Currency in USD
64.96
-0.49 (-0.75%)
At close: 3:38PM EDT
Stock chart is not supported by your current browser
Previous Close65.45
Open65.09
Bid60.78 x 800
Ask67.89 x 800
Day's Range64.60 - 65.09
52 Week Range59.58 - 77.35
Volume9,064
Avg. Volume15,154
Net Assets92.74M
NAV64.50
PE Ratio (TTM)N/A
Yield0.34%
YTD Return2.33%
Beta (3Y Monthly)1.24
Expense Ratio (net)0.35%
Inception Date2011-09-28
Trade prices are not sourced from all markets
  • Healthcare ETFs Sink on JNJ News, ACA Ruling: What???s Ahead?
    Zacks5 months ago

    Healthcare ETFs Sink on JNJ News, ACA Ruling: What???s Ahead?

    Healthcare took a hit recently on Johnson & Johnson news and a federal judge ruling. The rough trading also spread into the ETF world.

  • Top Sector ETFs of 2018
    Zacks5 months ago

    Top Sector ETFs of 2018

    These sector ETFs exceled in 2018 despite a few severe broader market crashes.

  • Midterms Produce Split Congress: ETF Areas in Focus
    Zacks6 months ago

    Midterms Produce Split Congress: ETF Areas in Focus

    These ETF investing areas may see some changes in the coming days as midterms delivered a split congress.

  • Must-Watch ETF Areas Before Mid-Term Elections
    Zacks7 months ago

    Must-Watch ETF Areas Before Mid-Term Elections

    These ETF areas should be watched closely ahead of mid-term.

  • Investopedia7 months ago

    Elections Could Affect These Health Care ETFs

    The Health Care Select Sector SPDR ETF ( XLV), the largest exchange-traded fund (ETF) tracking health care stocks, is up nearly 6% year to date, highlighting strength in the S&P 500's second largest sector weight.

  • DaVita’s Valuation on September 17
    Market Realist8 months ago

    DaVita’s Valuation on September 17

    DaVita (DVA) is a biotechnology company focused on the discovery, development, and commercialization of specialist medicines to cater to the medical needs in rare diseases and other specialized conditions. DaVita reported non-GAAP EPS of $1.15 on revenues of $2.9 billion, a 6.9% growth YoY (year-over-year) compared to $2.7 billion in the second quarter of 2017.

  • ETF Trends8 months ago

    State Street Global Advisors Cross-Lists 29 ETFs in Mexico

    State Street Global Advisors announced that 29 additional SPDR ETFs with $33.56 billion in assets under management have been cross-listed on the International Quotation System (SIC) of the Mexican stock ...